IL-33 was also demonstrated in the B6.Lepob/ob mouse model to protect from metabolic syndrome, induce Th2 response and polarize macrophages to an M2 phenotype, but no data on Tregs was reported (Miller et al., 2010). The gene discussed is IL33; the disease is metabolic syndrome.